Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Zabala Innovation

Consultancy

www.zabala.eu/Mutilva, Belgium
1 profile visit

About

At Zabala Innovation, we are dedicated to driving change and fostering innovation across various sectors. Our team specializes in providing expert guidance on funding strategies, project management, and the commercialization of innovative ideas. With a robust network of partners and a deep understanding of European funding programs, we help businesses leverage their potential and achieve sustainable growth. Together, we turn visionary concepts into impactful solutions that benefit industries and communities alike.

Representatives

Consultant R&D EU fundings

Zabala Innovation

Marketplace (1)

  • Project cooperation

    Proposal Development & Project Management for Health and Mission Cancer

    Zabala Innovation supports Horizon Europe Health and Mission Cancer consortia with proposal development and project management, combining scientific expertise with extensive experience in EU R&D funding and project implementation.

    • Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
    • Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
    • Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
    • Clinical trials: HORIZON-HLTH-2027-01-DISEASE-10 Prevention and management of chronic non-communicable diseases in children and young people (GACD)
    • Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
    • Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
    • Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
    • Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
    Author

    Consultant R&D EU fundings at Zabala Innovation

    Brussels, Belgium